Par Drugs and Chemicals Limited — Others, 31-12-2024: Shareholders meeting

An Extra Ordinary General Meeting was held where shareholders voted on two significant resolutions. The first concerned a slump sale of existing assets—which includes land and machinery—expected to be completed by the end of 2025 for an estimated consideration of approximately ₹92.88 crores. The second resolution involves entering into the real estate, construction, and renewable energy sectors, reflecting a strategic pivot aimed at leveraging emerging opportunities. This shift may enhance the company's growth prospects and investor sentiment, potentially indicating a positive outlook for future performance. Voting results will be disclosed shortly.